Shock Energy for Electrical Cardioversion of Persistent Atrial Fibrillation
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.
Also called NCT05903170
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 100 participants
- Sponsor
- Wellington Hospital
- Registry
-
NCT05903170
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- New Zealand
- Registry status
- Recruiting
Technical summary
Registry record NCT05903170. Randomized; no masking; primary purpose treatment. Start 2025-08 (anticipated); primary completion 2026-05 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Shock Energy for Electrical Cardioversion of Persistent Atrial Fibrillation
- Condition
- Atrial Fibrillation
- Intervention (Device)
- 360J LifePak Monitor/Defibrillator
- Intervention (Device)
- 200J Philips HeartStart MRx Monitor/Defibrillator
- Lead sponsor
- Wellington Hospital
Record details
- Record id
cardio:ct-nct05903170- Content hash
3037eb70ca8218e2e57ccde0896275249907788412b405034b161b1e980f76c5